MedTrace Logo

Nutritional Tolerance and Safety of a Tube Feeding Formula

NCT05848583 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-11-06

No results posted yet for this study

Summary

This open-label, prospective study will be conducted to assess the nutritional efficacy, safety, and tolerance of a concentrated, enteral formula in medically stable adults, who currently require or will require to be enterally fed.

Conditions

  • Enteral Feeding

Interventions

OTHER

Compleat 1.5

EN Formula

Sponsors & Collaborators

  • Bruyère Health Research Institute.

    collaborator OTHER

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Jean Chouinard, MD · Bruyère Health Research Institute.

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-11-15
Completion
2023-11-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05848583 on ClinicalTrials.gov